logo-loader
RNS
viewSativa Group PLC

Sativa Group PLC - Resumption of Share Trading

RNS Number : 8935O
Sativa Group PLC
04 June 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. 

 

 

Sativa Group Plc

("Sativa" or the "Company" or the "Group")

 

Resumption of Share Trading

 

4 June 2020

 

Sativa Group Plc (AQSE: SATI), the UK's leading quoted CBD wellness and medicinal cannabis company, is pleased to announce the resumption of share trading in the Company's Ordinary Shares is due to recommence. The shares were suspended pending a firm intention to make an offer from StillCanna Inc. The Scheme of Arrangement terms have now been agreed and were announced yesterday, 3 June 2020. Implementation of the Scheme of Arrangement is still subject to regulatory and Sativa shareholder approval. The Company is currently working on a Scheme Document that is expected to be sent to shareholders within 28 days of yesterday's announcement.  

 

Simultaneously with the Scheme of Arrangement becoming effective, StillCanna Inc. will also seek a fast-track admission to the AQSE Growth Market. This will facilitate easy trading of the combined company shares in the UK. The expected timing of the listing is estimated to be at the time of the closing of this transaction, or shortly thereafter.

 

Accordingly, trading in the Company's Ordinary Shares on AQSE Growth Market is expected to resume today at 8.30 am.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc

+44 (0) 20 7971 1255

[email protected]

www.sativagroup.co.uk

 

Joseph Colliver

Chief Financial Officer

Sativa Group Plc

+44 (0) 20 7971 1255

[email protected]

www.sativagroup.co.uk

 

AQSE Growth Market Corporate Adviser

Corporate Finance 

Guy Miller/Allie Feuerlein

Peterhouse Capital Limited

+44 (0) 20 7220 9795


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NEXBXLLBBQLXBBE

Quick facts: Sativa Group PLC

Price: 2.3

Market: AQSE
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (AQSE:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18